Data match
Available product attributes align at a stated Medimapper match level.
REGULATED CROSS-BORDER CONTEXT
Know what a medicine match really means.
Medimapper can identify related medicine records, presentations and markets. Whether a product may be imported, distributed, marketed or supplied is a separate assessment. That assessment is specific to the product, the parties and the jurisdictions.
DATA ALIGNMENT IS NOT TRADE PERMISSION
Comparable products are the start of the investigation.
Possible pathway
A regulatory or commercial route may exist for the product, parties and jurisdictions.
External verification
Qualified specialists and authorities assess the specific activity, responsibilities and evidence.
THINK IN PATHWAYS, NOT SIMPLE TRADE ZONES
The applicable route depends on the product and jurisdictions.
Parallel distribution in the European Union
For a centrally authorised medicine, distribution between EU Member States can fall under the EU parallel-distribution framework. Applicable notification, product, packaging, language, pharmacovigilance and distribution requirements still apply.
Parallel import of nationally authorised medicines
A destination-country authority generally assesses whether the imported product is sufficiently similar to the reference product and whether national requirements are met.
Imports from outside the EU and EEA
Third-country imports can require appropriate authorisations, quality oversight, GMP compliance, batch certification or testing and a valid market route.
Mutual-recognition agreements
These agreements can reduce duplicated regulatory work in covered areas. They are not blanket product or market authorisations.
WHAT MEDIMAPPER DOES
Market and product intelligence with a clear boundary.
Medimapper helps you
- Compare national product records and presentations
- Identify related products in selected source data
- Review local and normalised attributes
- Analyse product presence and national assortments
- Keep source links and known data limitations visible
Medimapper does not
- List medicines for sale or invite bids
- Accept orders, payments or inventory transactions
- Broker or execute medicine transactions
- Decide clinical or regulatory equivalence
- Replace quality, regulatory, legal or commercial due diligence
REGULATED PARTICIPANTS
The product and the parties both matter.
What has to be verified per party.
- Marketing authorisation and the applicable route
- Manufacturing, import and wholesale-distribution authorisations
- GMP and GDP status
- Packaging, labelling, language and serialisation requirements
- Product-specific, intellectual-property and pharmacovigilance responsibilities
FROM DATA SIGNAL TO REGULATED DECISION
Use better data at the beginning of the process.
- 01
Identify
Find a related substance, presentation, pack or commercial item.
- 02
Verify the data
Review local records, normalised attributes, identifiers and source links.
- 03
Assess the pathway
Determine the applicable requirements with qualified specialists and authorities.
- 04
Verify the parties
Confirm licences, roles, responsibilities and applicable quality systems.
- 05
Continue outside Medimapper
Negotiation, contracts, orders, payment and supply activity take place outside the platform.
START WITH PRODUCT COMPARISON